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Epidermal Cytokine Responses to Cyclosporin A in Psoriasis: Answering the T-cell Wake-Up Call 
In this issue, two articles from the University of Michigan explore 
[he mechanism of action of antipsoriatic drug, CsA. The authors 
measured cytokine expression in psoriatic lesions before and after 
one week of CsA therapy, prior to any detectable clinical improve-
ment, reasoning that studies of effects occurring before clinical im-
provement w.ould reveal primary changes relevant to the path~g.en­
esis of the disease and not secondary changes caused by clullcal 
improvement. In the first article, Elder et al (p 761) measured IL-8 
and IL-1 mRNA in vivo and IL-8 and ICAM-1 mRNA levels in vitro. 
In the second article, Kojima et al (p 767) extended these studies to 
three recent additions to the chemokine family, gro-C\', /3, and )" 
using polymerase chain reaction-based methods. The studies 
showed that, first, the expression of cytokine transcripts was highly 
variable in psoriatic lesions, and lesions that expressed high levels of 
IL- 1P -were also high expressers of IL-8 and gro. In contrast, 
CRAEP-II mRNA showed no such variability but was elevated to a 
similar degree in all psoriatic lesions. Second, the expression of all 
three cytokine transcripts was markedly reduced by CsA before 
clinical improvement occurred. Although expression of all three 
cytokme transcnpts was reduced approximately 80% by CsA, 
CRABP-II transcripts were nearly unaffected (5%), and the Psoria-
sis Area and Severity Index was unaffected after the one-week treat-
ment interval. Third, CsA had no effect on the cytokine stimulation 
of ~L-8 and ICAM-1 mRNAs in cultured keratinocytes. Finally, 
KOJlm~ et al demonstrated that of the three highly related gro genes, 
gro-C\' I.S selectively overexpressed in psoriatic lesions, and that gro 
transcnpts display the same pattern of differential CsA responsive-
ness in vivo versus itl vitro as do IL-8. Taken together, these results 
argue .that psoriatic keratillocytes overexpress all three cytokine 
genes m response to a common, CsA-responsive stimulus and that 
these keratinocyte cytoki~e responses are relevant to the pathogen-
eSIS of ~he dl~ease .. Assummg that the primary mechanism of CsA 
actlO~ IS the mlll.bltlOn of T -cell activation by antigen-presenting 
cells 111 the drall1mg lymph node, these results are consistent with 
the inactivity of topical CsA in this disease. 
Communicating Junctions in Epidermis 
Gap junctions are transmembrane channels that link adjacent cells 
and mediate exchanges of low-molecular-weight metabolites and 
ions; they may function in metabolic homeostasis, cellular differen-
tiation, and growth control. The channels are composed of subunit 
proteins called connexins (Cx), homologous proteins encoded by a 
gene family. Kam et al (j Invest DerlllatoI87:748-753, 1986) and 
Salomon et al (j Clin Izlllest 82:248, 1988) performed functional 
assays of the gap junction in epidermis using the dye-transfer 
method, in which dye injected into a cell is observed to spread to 
adjacent cells, a phenomenon that requires gap junctions. They 
showed that gap-junctional intercellular communication in epider-
mis was restricted to vertical compartments, possibly related to the 
organization of the epidermal proliferative unit. Guo et al (J bwest 
Dermatol 99:460-467, 1992) reported that rctinoic acid, which 
modulates proliferation and differentiation ofkeratinocytes, altered 
the expression of connexins. In this issue, Kamibayashi et al (p 773) 
used antibodIes to speCific connexin isoforms (Cx26, Cx32, and 
Cx43) to study connexins in epidermis and asked whether the ex-
f'ress!01~ of connexins is modulated during keratinocyte differentia-
~lOn III lIltact ?10USe skm. They found that Cx26 was expressed in 
keratlllocytes m the granular layer and the upper part of the spinous 
layer, whereas Cx43 was localized to the basal layer and the lower 
part of the spinous layer. About half of the keratinocytes in the 
upper part of the spinous layer expressed both Cx26 and Cx43. In 
most cases, however, Cx26 was localized on the upper surface, 
whereas Cx43 ,was present on the lower surface of the plasma mem-
brane of keratmocytes. These results suggest that modulation of 
connexin expression from Cx43 to Cx26 takes place in the epider-
mis during keratinocyte differentiation. The specific functions of 
the different connexins is not known. 
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Where Do Pemphigoid Autoantibodies Bind? 
The majority of patients with bullous pemphigoid (BP) have circu-
lating autoantibodies specific for the 230-kD hemidesmosomal 
protein now designated BPAG 1. The precise sites (epitopes) on the 
molecule that are the targets of autoantibodies are unknown, al-
though previous work has identified some regions of antibody reac-
tivity within the carboxyl terminal domain. Investigators speculate 
that these epitopes may identify regions critical in the normal func-
tion of this BP antigen, because the action of pathogenic antibody 
may be to disrupt function. To determine if sites outside of the 
carboxyl region of the molecule are important in autoantibody 
binding, Miller et al (p. 779) generated five fusion proteins from 
different regions of BPAG 1 and asked if sera from patients with BP 
would bind to these proteins. Antibodies in 80% of the sera bound to 
at least one of three regions located near either end of the predicted 
coiled-coil domain in the middle of the molecule. This region is 
thought to be important in self-aggregation of the antigen into 
presumed oligomers needed to build the hemidesmosome structure. 
Some sera reacted with more than one region. The sera did not react 
with two proteins generated from the middle of the coiled-coil 
region and the amino terminus, however, showing that the reac-
tions were specific. These findings demonstrate that regions of 
BPAG 1 outside of the carboxyl terminal region may be important in 
the binding of autoantibodies in BP and confirm previous demon-
strations that autoantibodies from a single patient may react with 
more than one site on the antigen. The demonstration of binding to 
regions of BPAG 1 at ei ther end of the coiled-coil region suggests 
that this region may be important in the formation of hemidesmo_ 
somes or in the maintenance of epidermal-dermal cell adherence. 
A New Type of Junction at the Cutaneous Basement Membrane? 
Adherens junctions are structural junctions between epithelial cells 
that resemble desmosomes, but instead of being associated with 
keratin filaments, as desmosomes are, they are connected to cables 
composed of the contractile protein actin. Adherens junctions are 
also composed of a distinct group of proteins; although plakoglobin 
is present in both desmosomes and adherens junctions, vinculin is 
characteristic of all types of adherens junction described so far. In 
vitro, cells produce two types of adherens junctions, cell-cell junc-
tions and cell-substrate junctions known as focal adhesions. Both 
fibroblasts and epithelial cells have focal adhesions, but fibroblasts 
lack cell-cell junctions, in contrast to epithelial cells, which are able 
to form cell-cell contact. The in vivo correlate of the focal adhesion 
has not been fully elucidated, especially in epithelial cells. 
In this issue, Kaiser et al (p 783) show that tal in, a component of 
the focal adhesion that can be demonstrated in vitro in both fibro-
blasts and epithelial cells, can be localized by immunofluorescence 
in the region of the basement membrane of human epidermis. Vin-
culin, which has been shown previously to be present in cell-cell 
junctions in epidermis, was also found to be present at the basal 
aspect of the epidermis. Immunoblotting confirmed that the pro-
teins were present. These studies indicate that it is likely that the 
focal adhesion in vitro has some kind of correlate structure itl vivo in 
the region of the basement membrane and that hemidesmosomes 
are therefore not the only cell-substrate junctional structure. There 
appears to be an actin-based structure like a cell-cell adherens junc-
tion at the basement membrane. In addition, because talin is known 
to bind to integrins, and because integrins are known to be involved 
in conveying signals from the extracellular milieu to the interior of 
the cell, these junctions may be involved in differentiation. Adher-
ens junctions are more difficult to demonstrate by electron micros-
copy than are desmosomes and have not yet been demonstrated in 
epidermis by immunoelectron microscopy. A second paper, also by 
Kaiser et al (p 789) describes the presence of an erythrocyte mem-
brane skeleton protein, adducin, another protein known to be able 
to associate with actin, in epidermis; this protein is not known to be 
a part of junctions, however, and its function requires further study. 
Can PCR Be Used in the Staging of Melanoma? 
The prognostic significance of detection of single tumor cells was 
shown for breast and gastrointestinal cancer using monoclonal anti-
bodies specific for cytokeratin. Tyrosinase, a key enzyme in melanin 
biosynthesis, has been proposed as a probe for detection of mela-
noma cells in peripheral blood, because it is expressed only in mela-
nocytes and melanoma cells, and because pigment cells are not ordi-
narily found in the circulation. On the premise that detection of 
tyrosinase RN A in peripheral blood should indicate the presence of 
melanoma cells, Brossart et al (p 887), tested samples of peripheral 
blood from 56 patients known to have melanoma by reverse tran-
scription of the mRNA and polymerase chain reaction. Initial stud-
ies showed that the method could detect one melanoma cell in 5 m! 
of blood, and the authors found that one of 10 patients with local-
ized disease (stage I), six of 17 patients with regional lymph node 
metastases (stage II), and 29 of 29 patients with widespread disease 
(stage 1lI), but none of 56 controls, had tyrosinase transcripts in 
peripheral blood. The authors speculate that this approach may help 
define patients at high risk for development of hematogeneous me-
tastases and in whom adjuvant therapy might be more useful. 
